UA100551C2 - Synbiotic mixture - Google Patents

Synbiotic mixture

Info

Publication number
UA100551C2
UA100551C2 UAA201012139A UAA201012139A UA100551C2 UA 100551 C2 UA100551 C2 UA 100551C2 UA A201012139 A UAA201012139 A UA A201012139A UA A201012139 A UAA201012139 A UA A201012139A UA 100551 C2 UA100551 C2 UA 100551C2
Authority
UA
Ukraine
Prior art keywords
preparation
lactosamine
acetyl
synbiotic
mixture
Prior art date
Application number
UAA201012139A
Other languages
English (en)
Ukrainian (uk)
Inventor
Норберт Спренгер
Original Assignee
Нестек С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Нестек С.А. filed Critical Нестек С.А.
Publication of UA100551C2 publication Critical patent/UA100551C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pediatric Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Данное изобретение касается препарата, который содержит N-ацетил-лактозамин и/или олигосахарид, который содержит N-ацетил-лактозамин, и пробиотикОлигосахарид, который содержит N-ацетил-лактозамин, является лакто-N-тетраозой или лакто-N-неотетраозой, а пробиотикомявляетсяАТСС 53103,CGMCC 1.3724,ATCC 55730 илиDSM 17938. Изобретение также касается нутрицевтической композиции, которая содержит указанный препарат, и применения препарата для профилактики и лечения патогенных инфекций желудочно-кишечного тракта, верхнего респираторного тракта и средних отитов.
UAA201012139A 2008-03-14 2009-02-24 Synbiotic mixture UA100551C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08152765 2008-03-14
PCT/EP2009/052166 WO2009112361A2 (en) 2008-03-14 2009-02-24 Synbiotic mixture

Publications (1)

Publication Number Publication Date
UA100551C2 true UA100551C2 (en) 2013-01-10

Family

ID=39780479

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201012139A UA100551C2 (en) 2008-03-14 2009-02-24 Synbiotic mixture

Country Status (15)

Country Link
US (3) US8961953B2 (ru)
EP (1) EP2265135B1 (ru)
CN (1) CN102006788A (ru)
AU (1) AU2009224814B2 (ru)
BR (1) BRPI0909289A2 (ru)
CA (1) CA2718222A1 (ru)
ES (1) ES2658837T3 (ru)
MX (1) MX2010009978A (ru)
MY (1) MY169947A (ru)
PT (1) PT2265135T (ru)
RU (1) RU2495927C2 (ru)
SG (1) SG188887A1 (ru)
UA (1) UA100551C2 (ru)
WO (1) WO2009112361A2 (ru)
ZA (1) ZA201007327B (ru)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0712844A2 (pt) * 2006-06-13 2012-07-31 Nestec Sa prevenÇço e tratamento da otite mÉdia com cepas bacterianas nço patogÊnicas.
CN101273738B (zh) * 2007-03-28 2011-06-01 哈尔滨正方科技有限公司 在常温下保持高活菌数的调配型酸性乳饮料的制备方法
US8498729B2 (en) 2008-08-29 2013-07-30 Smp Logic Systems Llc Manufacturing execution system for use in manufacturing baby formula
AU2011209407B2 (en) * 2010-01-28 2014-02-27 Ab-Biotics S.A. Probiotic composition for use in the treatment of bowel inflammation
MY166945A (en) 2010-12-31 2018-07-25 Abbott Lab Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
ES2667393T3 (es) 2010-12-31 2018-05-10 Abbott Laboratories Oligosacáridos de leche humana para modular inflamación
US8802650B2 (en) 2010-12-31 2014-08-12 Abbott Laboratories Methods of using human milk oligosaccharides for improving airway respiratory health
CA2822490C (en) 2010-12-31 2020-03-31 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
JP5331156B2 (ja) 2011-04-28 2013-10-30 シャープ株式会社 投光ユニットおよび投光装置
CA2839524C (en) 2011-06-20 2016-05-17 H.J. Heinz Company Probiotic compositions and methods
WO2013057072A1 (en) * 2011-10-18 2013-04-25 Nestec S.A. Composition for use in the promotion of magnesium absorption and/or magnesium retention
KR101381794B1 (ko) * 2012-04-10 2014-04-07 씨제이제일제당 (주) 타가토스 및 프로바이오틱 유산균을 함유하는 신바이오틱 식품 조성물
EP2928325A1 (en) * 2012-12-10 2015-10-14 N.V. Nutricia Nutritional composition with non digestible oligosaccharides
CN105722515A (zh) 2013-11-15 2016-06-29 雀巢产品技术援助有限公司 用于预防或治疗有风险婴儿或幼儿的urt感染的组合物
WO2015140299A1 (en) 2014-03-20 2015-09-24 Universiteit Antwerpen Oronasopharyngeal probiotics
MX378680B (es) 2015-03-05 2025-03-11 Soc Des Produits Nestle S A Star Composiciones para usar en la prevencion o el tratamiento de infecciones/inflamaciones gastrointestinales en infantes o niños pequeños.
CN114532538A (zh) 2015-03-05 2022-05-27 雀巢产品有限公司 用于预防或治疗婴儿或幼儿的耳炎或支气管炎的组合物
NZ750365A (en) 2016-07-28 2022-07-01 Fonterra Cooperative Group Ltd Dairy product and process
GB202415791D0 (en) * 2024-10-25 2024-12-11 Infant Bacterial Therapeutics Ab Uses and methods

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
WO1991016449A1 (en) 1990-04-16 1991-10-31 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
ATE172245T1 (de) 1992-07-06 1998-10-15 Nestle Sa Milchbakterien
DK0577903T3 (da) 1992-07-06 1998-04-06 Nestle Sa Antigastritisk middel
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
US6045854A (en) * 1997-03-31 2000-04-04 Abbott Laboraties Nutritional formulations containing oligosaccharides
EP1034787A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
AUPQ275799A0 (en) * 1999-09-10 1999-10-07 Luminis Pty Limited Recombinant bacterium expressing an oligosaccharide receptor mimic
US20040176320A1 (en) * 2001-06-29 2004-09-09 Jari Natunen Use of at least one glycoinhibitor substance
DK1531832T3 (da) * 2002-06-28 2009-07-27 Glykos Finland Oy Terapeutiske sammensætninger til anvendelse ved profylakse eller behandling af diarré
GB0308104D0 (en) * 2003-04-08 2003-05-14 Novartis Nutrition Ag Organic compounds
AU2005224162A1 (en) * 2004-03-19 2005-09-29 Danisco A/S Emulsifier composition for shortening
PT1629850E (pt) * 2004-08-24 2007-08-14 Nutricia Nv Composição nutricional que compreende a administração de oligossacarídeos indigeríveis
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
PL1993576T3 (pl) * 2006-03-07 2016-04-29 Nestec Sa Mieszanina synbiotyczna
CN101420966B (zh) 2006-03-10 2013-07-17 纽崔西亚公司 不可消化的糖用于在出生后给予婴儿最佳开始的用途
US7374924B2 (en) * 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
EP2060257A1 (en) * 2007-11-08 2009-05-20 Nestec S.A. Prevention and treatment of secondary infections following viral infection
WO2009060257A2 (en) 2007-11-09 2009-05-14 Acco Uk Limited Staple remover

Also Published As

Publication number Publication date
RU2495927C2 (ru) 2013-10-20
US20160106788A1 (en) 2016-04-21
MX2010009978A (es) 2010-11-30
CN102006788A (zh) 2011-04-06
EP2265135B1 (en) 2017-12-20
AU2009224814A1 (en) 2009-09-17
CA2718222A1 (en) 2009-09-17
ZA201007327B (en) 2018-11-28
RU2010142003A (ru) 2012-04-20
ES2658837T3 (es) 2018-03-12
US20110020304A1 (en) 2011-01-27
US8961953B2 (en) 2015-02-24
AU2009224814B2 (en) 2015-02-05
EP2265135A2 (en) 2010-12-29
US20130323216A1 (en) 2013-12-05
WO2009112361A3 (en) 2009-11-05
US9943556B2 (en) 2018-04-17
MY169947A (en) 2019-06-19
SG188887A1 (en) 2013-04-30
BRPI0909289A2 (pt) 2015-08-04
WO2009112361A2 (en) 2009-09-17
PT2265135T (pt) 2018-02-21
US9254303B2 (en) 2016-02-09

Similar Documents

Publication Publication Date Title
WO2009112361A3 (en) Synbiotic mixture
IN2012DN01638A (ru)
ZA200807879B (en) Use of bifidobacterium longum for the prevention and treatment of inflammation
SG10201901259RA (en) Prebiotic formulations and methods of use
UA102830C2 (ru) Профилактика условно-патогенных инфекций у лиц со сниженным иммунитетом
PH12013500931A1 (en) Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
MX2009012255A (es) Probioticos en ambiente pre y/o postquirurgico.
UA108198C2 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
MX2012005524A (es) Cepa de probioticos bifidobacterium.
UA97663C2 (ru) Применение bifidobacterium lactis cncm i-3446 для улучшения кишечной микробиоты у детей, родившихся путем кесарева сечения
PH12013502192A1 (en) Antibodies against human angiopoietin 2
NZ593708A (en) Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin
PL2219658T3 (pl) Kompozycja oparta na bakteriach probiotycznych w połączeniu z prebiotykiem i jej zastosowanie w zapobieganiu i/lub leczeniu schorzeń oddechowych i/lub infekcji oraz do polepszenia funkcjonalności jelit
UA109876C2 (ru) Композиция, содержащая bifidobacterium longum cncm i-2 618, для профилактики и лечения иммунных расстройств
PL1773361T3 (pl) Kompozycje oparte na bakteriach probiotycznych i ich zastosowanie w profilaktyce i/lub leczeniu patologii i/lub zakażeń układu oddechowego oraz poprawie funkcji jelit
MX346335B (es) Composiciones antisentido, y metodos para obtener y usar las mismas.
MX2010008137A (es) Bacterias no patogenas y/o atenuadas capaces de inducir apoptosis en macrofagos, proceso de fabricacion y su usos.
UA115520C2 (uk) Дієтична або фармацевтична композиція на основі лактобацил для вагінального або перорального введення
MX2015000338A (es) Novedosa cepa de lactobacillus crispatus.
PL2173196T3 (pl) Zastosowanie probiotyków i włókien w biegunce
WO2010008491A3 (en) Lactose compositions with decreased lactose content
GB2511993A (en) Prebiotic formulations and methods of use
BR112013028709A2 (pt) cepas bacterianas capazes de metabolizar oxalatos
UA107711C2 (en) Use of lactobacilli inhibiting gas producing coliform bacteria isolated from infants affected by colic
MY158310A (en) Prevention and treatment of allergic diarrhoea